JUVA Skin and Laser Center, New York, New York.
Suneva Medical, Inc, Irvine, California.
Dermatol Surg. 2021 Mar 1;47(3):365-369. doi: 10.1097/DSS.0000000000002809.
Although polymethylmethacrylate (PMMA)-collagen gel is approved for correction of nasolabial folds, there are no reports characterizing safety and efficacy in the midface, an area where fillers are often used in clinical practice.
To determine the safety and efficacy of PMMA-collagen gel for long-term volume restoration in the midface.
In this prospective, single-center, 12-month study, 23 subjects with a pretreatment Midface Volume Deficit Scale (MFVDS) grade of 3, 4, or 5 were treated with PMMA-collagen gel. Efficacy was measured by the investigator and blinded reviewers using the MFVDS at 3, 6, and 12 months. Subject Global Aesthetic Improvement Scale (SGAIS) and physician GAIS (PGAIS) ratings were collected at 3, 6, and 12 months.
Improvement in the MFVDS score from baseline was significant at all post-treatment time points (p < .0001). All subjects with baseline MFVDS grades of 5 (severe) or 4 (significant) had a grade of 0 (none) or 1 (minimal) at 12 months. Subject GAIS (SGAIS) and PGAIS ratings of improved or much improved were 100% at Month 3 and were maintained at 12 months (PGAIS = 100%, SGAIS = 91.3%). All adverse events were minor.
Polymethylmethacrylate-collagen gel is safe and effective for long-lasting correction of midface volume deficit.
聚甲基丙烯酸甲酯(PMMA)-胶原蛋白凝胶已被批准用于矫正鼻唇沟,但尚无关于其在中面部安全性和有效性的报道,而填充物在临床实践中常用于该区域。
评估 PMMA-胶原蛋白凝胶用于中面部长期体积修复的安全性和有效性。
在这项前瞻性、单中心、12 个月的研究中,23 名中面部容积缺损量表(MFVDS)评分为 3、4 或 5 的患者接受 PMMA-胶原蛋白凝胶治疗。采用 MFVDS 在治疗后 3、6 和 12 个月由研究者和盲法评估者评估疗效。在治疗后 3、6 和 12 个月收集患者整体美学改善量表(SGAIS)和医生整体美学改善量表(PGAIS)评分。
与基线相比,MFVDS 评分在所有治疗后时间点均显著改善(p<0.0001)。所有基线 MFVDS 评分为 5 级(重度)或 4 级(显著)的患者在 12 个月时均达到 0 级(无)或 1 级(轻度)。治疗后 3 个月时,患者 SGAIS 和 PGAIS 评分为改善或明显改善的比例为 100%,并在 12 个月时保持稳定(PGAIS=100%,SGAIS=91.3%)。所有不良事件均为轻度。
PMMA-胶原蛋白凝胶安全、有效,可持久矫正中面部容积缺损。